Partnership Opportunities

The 5th Annual RAS-Targeted Drug Development Summit was the perfect opportunity to showcase expert services, raise brand awareness, gain visibility, and position yourself as a thought leader in the RAS community.

Those who partnered with the only end-to-end RAS pathway forum met all the key RAS-targeted drug developers under one roof. They presented to influential stakeholders on how your solutions can enable them to tackle obstacles such as screening for potential drug candidates, developing assays, sequencing genomes, identifying suitable cancer models, performing diagnostics, and manufacturing pharmaceuticals.

Partners positioned themselves as thought leaders in the RAS community at the only industry dedicated end-to-end RAS pathway forum where they met all the key RAS targeted drug developers under one roof.

Who Attended? 

Screenshot 2023-05-09 142643
Screenshot 2023-05-09 142708

Why Partner?

Icon 1
Icon 2

Benefit from our market intelligence as we gather key insights into the biggest challenges that drug developers need your services to solve

Meet and network with industry powerhouses such as Amgen, Mirati Therapeutics, Roche, Novartis, Revolution Medicines, Genentech, Boehringer Ingelheim, Pfizer & more!

Conduct meaningful interactions and generate commercial opportunities with 9+ hours of built-in networking time

As 2023 has already seen monumental progress in cell therapy analytical development, ensure you are the go-to partner of choice for this next wave of cell-based and cell-directed therapies.

To learn more about our bespoke sponsorship packages, please get in touch at sponsor@hansonwade.com